Skip to main content
Figure 3 | BMC Research Notes

Figure 3

From: Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

Figure 3

Mean change in CGI-S from baseline to Week 52 by ADT group and week (efficacy sample, OC). Mean (SE) baseline CGI-S scores: bupropion plus aripiprazole, 4.2 (0.1); SSRI/SNRI plus aripiprazole, 4.2 (0.0). ADT, antidepressant treatment; CGI-S, Clinical Global Impressions–Severity score; OC, observed case; SNRI, serotonin–norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us